The integrated single-cell analysis developed an immunogenic cell death signature to predict lung adenocarcinoma prognosis and immunotherapy

Background: Research on immunogenic cell death (ICD) in lung adenocarcinoma (LUAD) has been relatively limited. This study aims to create ICD-related signatures for accurate survival prognosis prediction in LUAD patients, addressing the challenge of lacking reliable early prognostic indicators for t...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Pengpeng, Zhang, Haotian, Tang, Junjie, Ren, Qianhe, Zhang, Jieying, Chi, Hao, Xiong, Jingwen, Gong, Xiangjin, Wang, Wei, Lin, Haoran, Li, Jun, Huang, Chenjun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals 2023
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10599752/
https://www.ncbi.nlm.nih.gov/pubmed/37796202
http://dx.doi.org/10.18632/aging.205077

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10599752/
https://www.ncbi.nlm.nih.gov/pubmed/37796202
http://dx.doi.org/10.18632/aging.205077

Ejemplares similares